Docosahexaenoic acid and neurodevelopmental outcomes of term infants

Suzanne Meldrum; Karen Simmer

doi:10.1159/000448271

Docosahexaenoic acid and neurodevelopmental outcomes of term infants

Suzanne Meldrum, Karen Simmer

Research output: Contribution to journal › Article › peer-review

25 Citations (Web of Science)

Abstract

© 2016 S. Karger AG, Basel.Docosahexaenoic acid (DHA), a long-chain polyunsaturated fatty acid, is essential for normal brain development. DHA is found predominantly in seafood, fish oil, breastmilk and supplemented formula. DHA intake in Western countries is often below recommendations. Observational studies have demonstrated an association between DHA intake in pregnancy and neurodevelopment of offspring but cannot fully adjust for confounding factors that influence child development. Randomised clinical trials of DHA supplementation during pregnancy and/or lactation, and of term infants, have not shown a consistent benefit nor harm on neurodevelopment of healthy children born at term. The evidence does not support DHA supplementation of healthy pregnant and lactating women, nor healthy infants.

Original language	English
Pages (from-to)	23-28
Number of pages	6
Journal	ANNALS OF NUTRITION AND METABOLISM
Volume	69
Issue number	1
DOIs	https://doi.org/10.1159/000448271
Publication status	Published - 1 Nov 2016

Access to Document

10.1159/000448271

Cite this

@article{48f08e3cfa8f4043893bc4a52ca6c5b4,

title = "Docosahexaenoic acid and neurodevelopmental outcomes of term infants",

abstract = "{\textcopyright} 2016 S. Karger AG, Basel.Docosahexaenoic acid (DHA), a long-chain polyunsaturated fatty acid, is essential for normal brain development. DHA is found predominantly in seafood, fish oil, breastmilk and supplemented formula. DHA intake in Western countries is often below recommendations. Observational studies have demonstrated an association between DHA intake in pregnancy and neurodevelopment of offspring but cannot fully adjust for confounding factors that influence child development. Randomised clinical trials of DHA supplementation during pregnancy and/or lactation, and of term infants, have not shown a consistent benefit nor harm on neurodevelopment of healthy children born at term. The evidence does not support DHA supplementation of healthy pregnant and lactating women, nor healthy infants.",

author = "Suzanne Meldrum and Karen Simmer",

year = "2016",

month = nov,

day = "1",

doi = "10.1159/000448271",

language = "English",

volume = "69",

pages = "23--28",

journal = "ANNALS OF NUTRITION AND METABOLISM",

issn = "0250-6807",

publisher = "S Karger AG",

number = "1",

}

TY - JOUR

T1 - Docosahexaenoic acid and neurodevelopmental outcomes of term infants

AU - Meldrum, Suzanne

AU - Simmer, Karen

PY - 2016/11/1

Y1 - 2016/11/1

N2 - © 2016 S. Karger AG, Basel.Docosahexaenoic acid (DHA), a long-chain polyunsaturated fatty acid, is essential for normal brain development. DHA is found predominantly in seafood, fish oil, breastmilk and supplemented formula. DHA intake in Western countries is often below recommendations. Observational studies have demonstrated an association between DHA intake in pregnancy and neurodevelopment of offspring but cannot fully adjust for confounding factors that influence child development. Randomised clinical trials of DHA supplementation during pregnancy and/or lactation, and of term infants, have not shown a consistent benefit nor harm on neurodevelopment of healthy children born at term. The evidence does not support DHA supplementation of healthy pregnant and lactating women, nor healthy infants.

AB - © 2016 S. Karger AG, Basel.Docosahexaenoic acid (DHA), a long-chain polyunsaturated fatty acid, is essential for normal brain development. DHA is found predominantly in seafood, fish oil, breastmilk and supplemented formula. DHA intake in Western countries is often below recommendations. Observational studies have demonstrated an association between DHA intake in pregnancy and neurodevelopment of offspring but cannot fully adjust for confounding factors that influence child development. Randomised clinical trials of DHA supplementation during pregnancy and/or lactation, and of term infants, have not shown a consistent benefit nor harm on neurodevelopment of healthy children born at term. The evidence does not support DHA supplementation of healthy pregnant and lactating women, nor healthy infants.

U2 - 10.1159/000448271

DO - 10.1159/000448271

M3 - Article

C2 - 27842311

SN - 0250-6807

VL - 69

SP - 23

EP - 28

JO - ANNALS OF NUTRITION AND METABOLISM

JF - ANNALS OF NUTRITION AND METABOLISM

IS - 1

ER -

Docosahexaenoic acid and neurodevelopmental outcomes of term infants

Abstract

Access to Document

Fingerprint

Cite this